OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure, Activity and Function of the Protein Arginine Methyltransferase 6
Somlee Gupta, Rajashekar Varma Kadumuri, Anjali Kumari Singh, et al.
Life (2021) Vol. 11, Iss. 9, pp. 951-951
Open Access | Times Cited: 25

Showing 25 citing articles:

Targeting Arginine Methyltransferase PRMT5 for Cancer Therapy: Updated Progress and Novel Strategies
Jiahong Zheng, Bang Li, Yingqi Wu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8407-8427
Closed Access | Times Cited: 32

PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer
Qianzhi Chen, Qingyi Hu, Yan Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 10
Open Access | Times Cited: 22

Overview of the development of protein arginine methyltransferase modulators: Achievements and future directions
Chao Tong, Xiujin Chang, Fangui Qu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116212-116212
Closed Access | Times Cited: 11

PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B
Ji Wang, Zongyu Xiao, Peng Li, et al.
Oncogene (2023) Vol. 42, Iss. 14, pp. 1088-1100
Open Access | Times Cited: 15

The PRMT6/PARP1/CRL4B Complex Regulates the Circadian Clock and Promotes Breast Tumorigenesis
Tianshu Yang, Wei Huang, Tianyu Ma, et al.
Advanced Science (2023) Vol. 10, Iss. 14
Open Access | Times Cited: 15

Arginine methylation of ALKBH5 by PRMT6 promotes breast tumorigenesis via LDHA-mediated glycolysis
Xue Han, Chune Ren, Aifang Jiang, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 2, pp. 344-356
Closed Access | Times Cited: 6

Assessment of PRMT6-dependent alternative splicing in pluripotent and differentiating NT2/D1 cells
Matthias Eudenbach, Jonas Busam, Caroline Bouchard, et al.
Life Science Alliance (2025) Vol. 8, Iss. 4, pp. e202402946-e202402946
Open Access

PRMT3 and CARM1: Emerging Epigenetic Targets in Cancer
Jiaoti Huang, Bei-Ning Qiao, Yixin Yuan, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 4
Open Access

Ferroptosis hijacking by Mycobacterium tuberculosis
Boyi Gan
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12

Circadian rhythm disruption and endocrine-related tumors
Christos Savvidis, Efthymia Kallistrou, Eleni Kouroglou, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 7, pp. 818-834
Open Access | Times Cited: 3

Role of FOXO3a Transcription Factor in the Regulation of Liver Oxidative Injury
Hong Jin, Li Zhang, Jun He, et al.
Antioxidants (2022) Vol. 11, Iss. 12, pp. 2478-2478
Open Access | Times Cited: 14

Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy
Kritisha Bhandari, Wei‐Qun Ding
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3958-3958
Open Access | Times Cited: 2

Protein arginine methyltransferase 6 is a novel substrate of protein arginine methyltransferase 1
Mengtong Cao, You Feng, Y. George Zheng
World Journal of Biological Chemistry (2023) Vol. 14, Iss. 5, pp. 84-98
Open Access | Times Cited: 6

PRMT6 inhibits K63-linked ubiquitination and promotes the degradation of IRF3 in the antiviral innate immunity of black carp Mylopharyngodon piceus
Can Yang, Shisi Yang, Yujia Miao, et al.
Aquaculture (2022) Vol. 562, pp. 738872-738872
Closed Access | Times Cited: 5

PRMT6-FOXO3A ATTENUATES APOPTOSIS BY UPREGULATING PARKIN EXPRESSION IN INTESTINAL ISCHEMIA-REPERFUSION INJURY
Xinwan Wu, Zhou Yu, Hongjiao Xu, et al.
Shock (2024) Vol. 61, Iss. 5, pp. 791-800
Open Access

Overview of the PRMT6 Modulators in Cancer Treatment: Current Progress and Emerged Opportunity
Jinjin Peng, Bin Ni, Deping Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116857-116857
Closed Access

Effect of pollen treatments on fruit yield and gene expression in offshoot and tissue culture date palms (Phoenix dactylifera L. cv. Barhi)
Sara Alavipour, Esmaeil Khaleghi, Noorolla Moallemi, et al.
Plant Cell Tissue and Organ Culture (PCTOC) (2024) Vol. 159, Iss. 3
Closed Access

Special Issue “Structure, Activity, and Function of Protein Methyltransferases”
Arunkumar Dhayalan, Albert Jeltsch
Life (2022) Vol. 12, Iss. 3, pp. 405-405
Open Access | Times Cited: 2

Emerging epigenetic therapies: protein arginine methyltransferase inhibitors
Hannah Pook, Siim Pauklin
Elsevier eBooks (2023), pp. 613-634
Closed Access

PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B
Zhaotao Wang, Ji Wang, Zongyu Xiao, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top